Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts

Area of Science:

• Bone biology
• Cell differentiation
• Molecular regulation

Background:

• Osteoblasts are key regulators of bone formation and osteoclast differentiation.
• The role of Kruppel-like factor 4 (KLF4) in bone cell differentiation requires further elucidation.

Purpose of the Study:

• To investigate the role of KLF4 in osteoblast and osteoclast differentiation.
• To determine the molecular mechanisms by which KLF4 influences bone homeostasis.

Main Methods:

• Utilized co-culture systems of mouse bone marrow cells and osteoblasts.
• Performed overexpression and conditional knockout studies of KLF4 in osteoblasts.
• Analyzed gene expression, including receptor activator of nuclear factor κB ligand (RANKL) and Runx2 target genes.
• Investigated protein-protein interactions and promoter binding assays.

Main Results:

• KLF4 expression in osteoblasts is downregulated by 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3).
• Overexpression of KLF4 in osteoblasts inhibits 1,25(OH)2D3-induced osteoclast differentiation by downregulating RANKL expression.
• KLF4 directly binds to the RANKL promoter, repressing 1,25(OH)2D3-induced RANKL expression.
• Ectopic KLF4 overexpression in osteoblasts impairs osteoblast differentiation and mineralization by interacting with Runx2.
• Conditional knockout of KLF4 in osteoblasts leads to increased bone mass due to enhanced bone formation and increased osteoclast activity.

Conclusions:

• KLF4 acts as a negative regulator of both osteoclast and osteoblast differentiation.
• KLF4 plays a critical role in maintaining bone homeostasis.
• Targeting KLF4 may offer therapeutic strategies for bone diseases.